ABT-263 (Navitoclax) 100mg | 98.02%
APEXBIO TECHNOLOGY LLC
Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w Apoptosis|Bcl-2 Family
More Information Supplier PageABT-263 (Navitoclax)
Search Results
(±)12-HEPE 250 µg | ≥98%
Cayman Chemical
A non-enzymatic oxidation product of EPA that inhibits platelet aggregation
More Information Supplier Page(±)12-HEPE
(±)12-HEPE 100 µg | ≥98%
Cayman Chemical
A non-enzymatic oxidation product of EPA that inhibits platelet aggregation
More Information Supplier Page(±)12-HEPE
(±)12-HEPE 50 µg | ≥98%
Cayman Chemical
A non-enzymatic oxidation product of EPA that inhibits platelet aggregation
More Information Supplier Page(±)12-HEPE
(±)12-HEPE 25 µg | ≥98%
Cayman Chemical
A non-enzymatic oxidation product of EPA that inhibits platelet aggregation
More Information Supplier Page(±)12-HEPE
(±)12-HEPE 10mg | ≥98%
Musechem
(±)12-HEPE 1 mg | Purity Not Available
TargetMol
(±)12-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 12(S)-HEPE and 12(R)-HEPE. The biological activity of (±)12-HEPE is likely mediated by one of the individual isomers, most commonly the 12(S) isomer in mammalian systems. 12-HEPE inhibits platelet aggregation with the same potency as 12-HETE, exhibiting IC50 values of 24 and 25 […]
More Information Supplier Page(±)12-HEPE
(±)12-Hete inquiry | 95%
Alfa Chemistry
(±)12-HETE 250 µg | ≥95%
Cayman Chemical
(±)12-HETE
(±)12-HETE 100 µg | ≥95%
Cayman Chemical
(±)12-HETE
(±)12-HETE 50 µg | ≥95%
Cayman Chemical
(±)12-HETE